Q2BI
x
  • Home
  • OUR COMPANY
  • SOLUTIONS
    EDC & CDM> Biostat & Programming> NDA Submission> PK/PD> Clinical Operation> Consulting>
  • NEWS
    Company News> Industry News>
  • CAREER
    Career> Open Positions> School recruitment information>
  • CONTACT US
    Contact Us> Submit RFP>
  • Events
  • English
    English 简体中文 日本語
  • Submit RFP
Home / NewsNews Center
News Center
  • Company News
  • Industry News
  • 06-14 2022
    A world first! The US FDA, Australia's TGA and Health Canada approved lovastinib in combination with K, and Jena helped develop the drug
    This is the United States FDA since the establishment of oncology Center of Excellence (OCE) in 2017...
    Road 1 page 1 strip
OUR COMPANY
SOLUTIONS
EDC & CDM
Biostat & Programming
NDA Submission
PK/PD
Clinical Operation
Consulting
NEWS
Company News
Industry News
CAREER
Career
Open Positions
School recruitment information
CONTACT US
Contact Us
Submit RFP
Events

Copyright ©2018-now Q-square Business Intelligence , Corp.